This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Bayer Intellectual Property Gmbh. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Hannes-Friedrich Ulbrich: Innovator in Transdermal Drug Delivery
Introduction
Hannes-Friedrich Ulbrich is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of pharmaceutical formulation techniques, particularly in the development of transdermal drug delivery systems.
Latest Patents
Ulbrich holds a patent for "Low-dose transdermal patches with high drug release." This invention focuses on providing a low dosage pharmaceutical composition for the transdermal delivery of hormones, specifically a progestin such as Gestodene and an estrogen like Ethinylestradiol. The goal of this invention is to achieve plasma concentration profiles that are effective in inhibiting ovulation in women.
Career Highlights
Hannes-Friedrich Ulbrich is associated with Bayer Intellectual Property GmbH, where he continues to work on innovative pharmaceutical solutions. His expertise in drug delivery systems has positioned him as a key figure in the industry.
Collaborations
Ulbrich has collaborated with notable colleagues, including Ildiko Terebesi and Christian Zurth, to advance research and development in pharmaceutical formulations.
Conclusion
Hannes-Friedrich Ulbrich's work in transdermal drug delivery represents a significant advancement in pharmaceutical technology. His innovative approach continues to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile